Santosh Kesari MD PhD, and Colleagues Publish New Glioblastoma Papers
by Guest Author
August 2017: Nature Neuroscience
A TNF-JNK-Axl-ERK signaling axis mediates primary resistance to EGFR inhibition in glioblastoma.
May 2017: International Journal of Molecular Sciences
Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine.
Last updated: January 6th, 2020